Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia

about

Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia

Item

http://www.wikidata.org/entity/Q58696763

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@en

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@nl

type

Item

label

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@en

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@nl

prefLabel

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@en

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@nl

P1476

Clinical Experience with Cereb ...... viduals for Suspected Dementia

@en

P2093

Andrew F Teich

http://www.w3.org/2001/XMLSchema#string

Giuseppe Tosto

http://www.w3.org/2001/XMLSchema#string

Guy M McKhann Ii

http://www.w3.org/2001/XMLSchema#string

Lawrence S Honig

http://www.w3.org/2001/XMLSchema#string

Leonardo Tariciotti

http://www.w3.org/2001/XMLSchema#string

Matthew Casadei

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

pROC: an open-source package for R and S+ to analyze and compare ROC curves

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.

Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

P304

1417-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-180548

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard Mayeux

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30149454

http://www.w3.org/2001/XMLSchema#string

P921

clinical psychology

phosphorylation

dementia

P932

6218126

http://www.w3.org/2001/XMLSchema#string